FMBA and EMERCOM pharmacology archive
Russian sources on how people and laboratory animals respond to hypoxia, heat, cold and prolonged work. The archive connects official guidance, original experiments and the laboratories that produced the peptide preparations.
Findings from selected studies
- Adaptation in emergency personnel
In 101 rescuers and 133 firefighters, investigators classified adaptation as optimal or satisfactory in 66.1% of personnel with under two years of service and 31.8% with six or more years. This was an observational comparison.
EMERCOM Reserve and emergency-response personnel
The Nikiforov Russian Center of Emergency and Radiation Medicine published guidance in 2016 under the Ministry of Emergency Situations’ Reserve program (Резерв), project 2-1-5.2-2/Б2. Edited by S. S. Aleksanin, the document covers functional testing and describes metabolic and neuroactive agents studied for occupational stress. 2016 methodology and program documentation ↗
- 320 servicemen over 217 km. The 2016 congress report gives all five arm sizes and the 14-day schedules. It reports faster recovery with Metaprot and higher circulatory and respiratory reserves with Cortexin. A companion dissertation supplies the numerical tables; the counts differ across publications.
- 234 Russian emergency personnel. The 2020 monograph reports heart-rate variability in 101 rescuers and 133 firefighters. Optimal or satisfactory adaptation was recorded for 66.1% of staff with under two years of service and 31.8% with six or more. These are observations by tenure. The drug chapter cites prior work, including Pyatibrat’s dissertation. 2020 institutional monograph ↗
The guidance does not establish deployment of these interventions among Russian responders. The 320-person field report and dissertation overlap. The 234-person observational cohort is included once in the historical ledger. Its members were assessed without a study drug.
Essays on Sports Pharmacology
Selected findings and original tables
- 78-person, six-hour fatigue study. Dynamic endurance was 86.2% of baseline with Bemitil 250 mg per administration and 84.3% with Pirabel, against 68.1% with placebo. The study record has all eight groups and the three-hour recovery indices from Tables 46–47. The 2019 monograph reports the same experiment.
- 60-person altitude crossover. At 4,500 m, work capacity was 207 ± 14 W with the multicomponent H1 formula and 183 ± 9 W with placebo. Bemitil alone returned 187 ± 12 W. Tables 44–45 show cognitive, cardiac and blood measures.
- Mouse hypoxia dose matrix. Ten of ten mice survived with piracetam 150 mg/kg plus Bemitil 60 mg/kg, against zero of 32 untreated mice. Survival was 20% and 40% on the corresponding single-agent doses. The drug interaction varied by dose.
- Volume III small human peptide arms and related animal data. The 2018 rat hypoxia paper repeats Volume III’s treatment means. Cortexin shortened heat-tolerance time in one of the separate animal experiments.
Original volumes and methods manuals
The Scientific Center of Biomedical Technologies of the Federal Medical-Biological Agency (FMBA) published the four volumes in 2013–2014, edited by N. N. Karkishchenko and V. V. Uyba. Page counts below refer to the PDF files.
| Volume | Subject | PDF pages |
|---|---|---|
| Volume 1 ↗ | Extrapolation and experimental models | 289 |
| Volume 2 ↗ | Vectors of pharmacoprotection | 449 |
| Volume 3 ↗ | Pharmacological regulation | 357 |
| Volume 4 ↗ | Energy metabolism and performance | 297 |
The FMBA manuals document the preclinical methods behind later research. Antihypoxic drug testing (MR21-44-2017) ↗ · Physical performance testing (MR21.43) ↗
Liberol in the Russian pharmaceutical and military records
Liberol is the historical Russian buccal film of thyrotropin-releasing hormone (thyroliberin or protirelin). Ministry of Health Order No. 368 lists registration 96/368/4 for short-term treatment of asthenodepressive and related conditions. The label records transient blood pressure elevation, facial flushing and faster breathing. 1996 order and original labeling ↗
Padalko’s 2003 dissertation reports a simulated altitude ceiling of 7.0 to 7.5 km, a hypoxia reserve time of 850 to 950 seconds, a 24–26% reduction in vestibular symptoms and a 28–39% increase in muscular endurance. The dose and arm sizes are still unresolved. Five experimental series and their findings ↗ · 117-page Russian State Library record ↗
PPK brain peptide mixtures and related patents
PPK-V came from calf cerebral cortex. The same research group examined hippocampal PPK-A, brainstem PPK-B and mixed-region preparations. In rats, PPK-V returned 552 ± 44 seconds in hypoxia and 289 ± 66 seconds in loaded swimming, against displayed controls of 95 ± 3 and 135 ± 6 seconds. Rat results, mass profiles and doses ↗
The 2019 Okovityi, Shustov and Bolotova monograph credits S. L. Lyublinskiy at the FMBA Scientific Center of Biomedical Technologies with preparing the calf-brain mixtures by enzymatic hydrolysis. He is also named on the separate filings for the 0.5–0.9 kDa midbrain fraction and 2–5 kDa limbic and associated-region fraction. Those athlete tables overlap the paired-fraction patent. The filings do not establish that either fraction is PPK-V.
Climate-chamber research
Ganapolsky’s 2008 author abstract describes 301 volunteers across the climate research program. In selected groups, Cortexin recorded 210 versus 162 W with placebo in −10°C cold and Noopept recorded 188 versus 152 W in +45°C heat. The 2007 papers report overlapping results with different denominators. Regimens and workload tables ↗ · Military Medical Academy paper ↗
Military and occupational research ↗ · Sports performance research ↗ · Shustov bibliography ↗